Moreover, they found new evidence that YAP/TAZ can abnormally activate the target gene, BIRC5, accompanied with down-regulation of LATS1/2, in turn simulating aberrant cell growth and neoplasia in glioblastoma [88]. The gene discussed is YAP1; the disease is neoplasm.